Inspira™ receives israeli regulatory approval for the inspira™ art100 system

Approval follows the fda clearance announced on may 28, 2024  ra'anana, israel , july 11, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) (nasdaq: iinnw) (the "company" or "inspira"), a breakthrough medical technology company, is excited to announce the receipt of the israeli ministry of health's medical devices and accessories ("amar") approval for the inspira™ art100, an extra-corporeal membrane oxygenation and cardiopulmonary bypass system.
IINN Ratings Summary
IINN Quant Ranking